CD274 and triple-negative breast carcinoma: The RAS/MAPK pathway is a significant factor driving PD-L1 expression (77, 78), but its activation in triple-negative breast cancer is associated with reduced TIL infiltration (79, 80), which may cause immune escape and ICIs resistance.